Bruce Blough

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Results

Filter

Filter by Year

Search Results

The synthesis of haptens and their use for the development of monoclonal antibodies for treating methamphetamine abuse

Effects of L-methamphetamine treatment on cocaine- and food-maintained behavior in rhesus monkeys

Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter

Combining Active Immunization with Monoclonal Antibody Therapy To Facilitate Early Initiation of a Long-Acting Anti-Methamphetamine Antibody Response

Effects of 'Legal X' piperazine analogs on dopamine and serotonin release in rat brain: Current Status of Drug Dependence / Abuse Studies: Cellular and Molecular Mechanisms of Drugs of Abuse and Neurotoxicity

Pharmacology of novel synthetic stimulants structurally related to the 'bath salts' constituent 3,4-methylenedioxypyrovalerone (MDPV)

Synthesis and Monoamine Transporter Binding Properties of 3alpha-(Substituted-phenyl)nortropane-2beta-carboxylic Acid Methyl Esters. Norepinephrine Transporter Selective Compounds

The reinforcing and rewarding effects of methylone, a synthetic cathinonecommonly found in “bath salts”

Dopamine/serotonin releasers as medications for stimulant addictions

Dual Dopamine/Serotonin Releasers as Potential Medications for Stimulant and Alcohol Addictions

Transdermal formulation of 4-benzylpiperidine for cocaine-use disorder

The kappa-opioid receptor agonist, triazole 1.1, reduces oxycodone self-administration and enhances oxycodone-induced thermal antinociception in male rats

In vitro and in vivo characterization of a novel negative allosteric modulator of neuronal nAChRs

Effect of TRV130 and methadone on fentanyl-vs.-food choice and somatic withdrawal signs in opioid-dependent and post-opioid-dependent rats

In a rat model of opioid maintenance, the G protein-biased mu opioid receptor agonist TRV130 decreases relapse to oxycodone seeking and taking and prevents oxycodone-induced brain hypoxia

3 beta-(4-ethyl-3-iodophenyl)nortropane-2 beta-carboxylic acid methyl ester as a high-affinity selective ligand for the serotonin transporter

Cognitive-enhancing effects of acetylcholine receptor agonists in group-housed cynomolgus monkeys who drink ethanol

Studies of the Biogenic Amine Transporters. 14. Identification of Low-Efficacy 'Partial' Substrates for the Biogenic Amine Transporters

Phenylmorpholines and Analogues Thereof

Development of norepinephrine transporter reuptake inhibition assays using SK-N-BE(2)C cells